Dr Reddys Laboratories (RDY) Non Operating Income (2009 - 2023)
Dr Reddys Laboratories (RDY) posted quarterly Non Operating Income of -$15.0 million for Q2 2023, down 66.67% quarter-over-quarter from -$9.0 million in Q1 2023.
Dr Reddys Laboratories (RDY) Non Operating Income (2009 - 2023) Analysis & Trends
Dr Reddys Laboratories' Non Operating Income history runs 15 years deep, the most recent figure standing at -$15.0 million for Q2 2023.
- In Q2 2023, Non Operating Income changed N/A year-over-year to -$15.0 million; the TTM figure through Jun 2023 stood at -$34.0 million (changed N/A YoY), while the FY2026 annual figure was $44.0 million, down 20.0% from the prior year.
- Non Operating Income for Q2 2023 stood at -$15.0 million, down from -$9.0 million in the prior quarter.
- The five-year high for Non Operating Income was $40.0 million in Q1 2019, with the low at -$15.0 million in Q2 2023.
- The 5-year median for Non Operating Income is -$7.5 million (2020), against an average of -$2.5 million.
- The sharpest annual moves came in 2019 and 2020: Non Operating Income surged 2100.0% in 2019, then sank 120.0% in 2020.
- Dr Reddys Laboratories' Non Operating Income stood at $40.0 million in 2019, then slumped by 117.5% to -$7.0 million in 2020, then jumped by 42.86% to -$4.0 million in 2021, then slumped by 150.0% to -$10.0 million in 2022, then slumped by 50.0% to -$15.0 million in 2023.
- Business Quant data shows RDY's Non Operating Income at -$15.0 million in Q2 2023, -$9.0 million in Q1 2023, and -$10.0 million in Q4 2022.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.28 Bn | 39.62 Bn | 2.15 Bn | -224.00 Mn |
| 3 | Zoetis | 31.78 Bn | 30.11 Bn | 1.05 Bn | 5.00 Mn |
| 4 | Takeda Pharmaceutical | 28.71 Bn | 22.91 Bn | 5.10 Bn | - |
| 5 | United Therapeutics | 22.25 Bn | 19.59 Bn | 683.80 Mn | 41.90 Mn |
| 6 | Viatris | 18.72 Bn | 17.83 Bn | 1.46 Bn | - |
| 7 | Neurocrine Biosciences | 15.57 Bn | 15.18 Bn | 935.80 Mn | 10.70 Mn |
| 8 | Elanco Animal Health | 11.87 Bn | 11.34 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.97 Bn | - | - |
| 10 | Alkermes | 8.14 Bn | 7.48 Bn | 397.90 Mn | -20.23 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | -15.00 Mn |
| Mar 31, 2023 | -9.00 Mn |
| Dec 31, 2022 | -10.00 Mn |
| Sep 30, 2022 | 2.00 |
| Jun 30, 2021 | -4.00 Mn |
| Mar 31, 2021 | -9.00 Mn |
| Sep 30, 2020 | -7.00 Mn |
| Jun 30, 2020 | -3.00 Mn |
| Mar 31, 2020 | -8.00 Mn |
| Mar 31, 2019 | 40.00 Mn |
| Dec 31, 2018 | -15.00 Mn |
| Jun 30, 2018 | -9.00 Mn |
| Mar 31, 2018 | -2.00 Mn |
| Dec 31, 2017 | -15.00 Mn |
| Sep 30, 2017 | -13.00 Mn |
| Sep 30, 2016 | 1.00 Mn |
| Mar 31, 2016 | -7.00 Mn |
| Dec 31, 2015 | 40.00 Mn |
| Sep 30, 2015 | -15.00 Mn |
| Jun 30, 2015 | -6.00 Mn |